Published in Exp Dermatol on October 01, 2012
Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front Microbiol (2013) 1.42
Defensins: antifungal lessons from eukaryotes. Front Microbiol (2014) 0.99
Interplay between Candida albicans and the antimicrobial peptide armory. Eukaryot Cell (2014) 0.92
C. albicans growth, transition, biofilm formation, and gene expression modulation by antimicrobial decapeptide KSL-W. BMC Microbiol (2013) 0.83
Corpora Amylacea of Brain Tissue from Neurodegenerative Diseases Are Stained with Specific Antifungal Antibodies. Front Neurosci (2016) 0.78
Signaling domains of mucin Msb2 in Candida albicans. Eukaryot Cell (2015) 0.76
Anti-fungal activity of Ctn[15-34], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin. J Antibiot (Tokyo) (2016) 0.75
Integrated Activity and Genetic Profiling of Secreted Peptidases in Cryptococcus neoformans Reveals an Aspartyl Peptidase Required for Low pH Survival and Virulence. PLoS Pathog (2016) 0.75
The interaction of aurein 2.5 with fungal membranes. Eur Biophys J (2014) 0.75
Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev (1998) 9.76
A peptide antibiotic from human skin. Nature (1997) 7.64
Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem (2000) 6.19
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother (1997) 5.66
Mammalian defensins in the antimicrobial immune response. Nat Immunol (2005) 4.84
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev (2003) 4.07
The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem (1997) 3.82
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature (2011) 2.31
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J Invest Dermatol (2005) 2.19
RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem (2002) 1.99
Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol (2005) 1.85
Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol (2003) 1.82
Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol (2004) 1.74
Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol (2003) 1.70
Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology (2002) 1.41
Differential regulation of beta-defensin expression in human skin by microbial stimuli. J Immunol (2005) 1.41
Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomark Insights (2007) 1.40
Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis (1997) 1.39
In vitro candidastatic properties of the human neutrophil calprotectin complex. J Immunol (1993) 1.37
A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer (2010) 1.32
The antimicrobial activity of lactoferrin: current status and perspectives. Biometals (2004) 1.27
Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol (2005) 1.26
Salivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva. Adv Dent Res (2000) 1.21
Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob Agents Chemother (2006) 1.18
Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol (2005) 1.16
Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother (1999) 1.15
Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis. J Infect Dis (2006) 1.11
Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes. FEMS Microbiol Lett (1998) 1.11
Lysozyme distribution in healthy human skin. Arch Dermatol Res (1982) 1.11
Lytic action of lysozyme on Candida albicans. Mycopathol Mycol Appl (1970) 1.10
Targeting virulence: a new paradigm for antifungals. Drug Discov Today (2009) 1.05
Fungal strategies for overcoming host innate immune response. Med Mycol (2008) 1.02
Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS (2000) 1.00
Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3. Antimicrob Agents Chemother (2008) 0.99
HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol (1999) 0.96
Identification of an antifungal peptide from Trapa natans fruits with inhibitory effects on Candida tropicalis biofilm formation. Peptides (2011) 0.93
Chitinase activity in human serum and leukocytes. Infect Immun (1995) 0.92
Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontol 2000 (2010) 0.92
The antimicrobial heterodimer S100A8/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes. J Invest Dermatol (2010) 0.92
Inhibition of growth and secreted aspartyl proteinase production in Candida albicans by lysozyme. J Med Microbiol (1999) 0.88
Chitotriosidase and gene therapy for fungal infections. Cell Mol Life Sci (2009) 0.88
HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. FEMS Immunol Med Microbiol (2001) 0.87
X-ray structures of Sap1 and Sap5: structural comparison of the secreted aspartic proteinases from Candida albicans. Proteins (2008) 0.87
HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year study. Mycoses (1999) 0.87
The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans. APMIS (1997) 0.85
Antifungal activity of novel synthetic peptides by accumulation of reactive oxygen species (ROS) and disruption of cell wall against Candida albicans. Peptides (2011) 0.84
Expression and potential function of cathelicidin antimicrobial peptides in dermatophytosis and tinea versicolor. J Antimicrob Chemother (2006) 0.83
The secreted aspartic proteinases as a new target in the therapy of candidiasis. Curr Drug Targets (2002) 0.82
Human lysozyme possesses novel antimicrobial peptides within its N-terminal domain that target bacterial respiration. J Agric Food Chem (2011) 0.79
In vitro activity of synthetic antimicrobial peptides against Candida. Pol J Microbiol (2006) 0.78
Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans. J Med Microbiol (2003) 0.78
Plasma lysozyme levels and decay of neutrophilic granulocytes in patients with Crohn's disease. Hepatogastroenterology (1980) 0.76
T-helper-1-cell cytokines drive cancer into senescence. Nature (2013) 4.47
Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem (2005) 3.02
Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol (2005) 3.00
Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe (2010) 2.64
In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell Microbiol (2007) 2.35
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature (2011) 2.31
Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses (2005) 1.96
The siderophore iron transporter of Candida albicans (Sit1p/Arn1p) mediates uptake of ferrichrome-type siderophores and is required for epithelial invasion. Infect Immun (2002) 1.91
Proteins of nucleotide and base excision repair pathways interact in mitochondria to protect from loss of subcutaneous fat, a hallmark of aging. J Exp Med (2010) 1.86
Bartonella adhesin a mediates a proangiogenic host cell response. J Exp Med (2004) 1.84
Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect Immun (2002) 1.82
Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J Biol Chem (2005) 1.77
In vivo and ex vivo comparative transcriptional profiling of invasive and non-invasive Candida albicans isolates identifies genes associated with tissue invasion. Mol Microbiol (2007) 1.68
Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest (2007) 1.67
Human defensins. J Mol Med (Berl) (2005) 1.66
Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. Arch Dermatol (2011) 1.62
Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology (2008) 1.52
The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J Immunol (2011) 1.33
Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol (2004) 1.29
Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol (2010) 1.26
β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. PLoS One (2011) 1.25
Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy induction. Autophagy (2011) 1.24
Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells. Sci Signal (2013) 1.19
Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice. Microb Pathog (2002) 1.15
Virulence of the fungal pathogen Candida albicans requires the five isoforms of protein mannosyltransferases. Infect Immun (2005) 1.15
Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Res (2012) 1.14
Toll-like receptors and innate antifungal responses. Trends Microbiol (2004) 1.14
Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes. PLoS One (2010) 1.14
Infection of human CD34+ progenitor cells with Bartonella henselae results in intraerythrocytic presence of B. henselae. Blood (2005) 1.12
Candida albicans-epithelial interactions: dissecting the roles of active penetration, induced endocytosis and host factors on the infection process. PLoS One (2012) 1.12
Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Infect Immun (2005) 1.11
Phage release from biofilm and planktonic Staphylococcus aureus cells. FEMS Microbiol Lett (2005) 1.11
Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium. J Med Microbiol (2003) 1.11
IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur J Immunol (2011) 1.11
Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res (2011) 1.10
Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654. FEBS Lett (2010) 1.10
Persistence versus escape: Aspergillus terreus and Aspergillus fumigatus employ different strategies during interactions with macrophages. PLoS One (2012) 1.08
Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol (2007) 1.07
Rosacea - S1 guideline. J Dtsch Dermatol Ges (2013) 1.06
Yersinia enterocolitica induces apoptosis and inhibits surface molecule expression and cytokine production in murine dendritic cells. Infect Immun (2004) 1.06
Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. Antimicrob Agents Chemother (2003) 1.06
Targeting virulence: a new paradigm for antifungals. Drug Discov Today (2009) 1.05
Sideromycins: tools and antibiotics. Biometals (2009) 1.04
Localization and functionality of the inflammasome in neutrophils. J Biol Chem (2014) 1.00
The impact of erythrocyte age on eryptosis. Br J Haematol (2012) 1.00
Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access. Radiother Oncol (2011) 0.98
Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammation. Blood (2009) 0.98
Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. Inflamm Bowel Dis (2007) 0.97
Induction of nuclear factor- kappa B and c-Jun/activator protein-1 via toll-like receptor 2 in macrophages by antimycotic-treated Candida albicans. J Infect Dis (2004) 0.97
Generation of a novel rodent model for DYT1 dystonia. Neurobiol Dis (2012) 0.96
The NFĸB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated Erythrocytes. Cell Physiol Biochem (2011) 0.96
Eosinophilic fasciitis and combined UVA1--retinoid--corticosteroid treatment: two case reports. Acta Derm Venereol (2008) 0.95
Characterization of an Enterococcus faecium small-colony variant isolated from blood culture. Int J Med Microbiol (2011) 0.94
Bacteria induce CTGF and CYR61 expression in epithelial cells in a lysophosphatidic acid receptor-dependent manner. Int J Med Microbiol (2007) 0.94
Host-pathogen interactions and virulence-associated genes during Candida albicans oral infections. Int J Med Microbiol (2011) 0.94
The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells. J Invest Dermatol (2010) 0.94
Oxidized LDL-activated platelets induce vascular inflammation. Semin Thromb Hemost (2010) 0.94
A young woman with recurrent vesicles on the lower lip: fixed drug eruption mimicking herpes simplex. Acta Derm Venereol (2008) 0.94
Bartonella henselae inhibits apoptosis in Mono Mac 6 cells. Cell Microbiol (2005) 0.93
Yersinia YopP-induced apoptotic cell death in murine dendritic cells is partially independent from action of caspases and exhibits necrosis-like features. Apoptosis (2006) 0.92
Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. Med Mycol (2009) 0.92
PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro. DNA Repair (Amst) (2008) 0.92
[Cellulite--the greatest skin problem in healthy people? An approach]. J Dtsch Dermatol Ges (2006) 0.92
In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue. J Nucl Med (2014) 0.90
Pathophysiology of acne. J Dtsch Dermatol Ges (2007) 0.90
The early transcriptional response of human granulocytes to infection with Candida albicans is not essential for killing but reflects cellular communications. Infect Immun (2006) 0.89
Bartonella quintana variably expressed outer membrane proteins mediate vascular endothelial growth factor secretion but not host cell adherence. Infect Immun (2006) 0.89
The Candida albicans cell wall protein Rhd3/Pga29 is abundant in the yeast form and contributes to virulence. Yeast (2010) 0.89
Impaired mast cell activation in gene-targeted mice lacking the serum- and glucocorticoid-inducible kinase SGK1. J Immunol (2009) 0.89
Yersinia outer proteins E, H, P, and T differentially target the cytoskeleton and inhibit phagocytic capacity of dendritic cells. Int J Med Microbiol (2007) 0.89
Unusual trafficking pattern of Bartonella henselae -containing vacuoles in macrophages and endothelial cells. Cell Microbiol (2005) 0.88
Nodular malignant melanoma and multiple cutaneous neoplasms under immunosuppression with azathioprine. Melanoma Res (2009) 0.88
X-ray structures of Sap1 and Sap5: structural comparison of the secreted aspartic proteinases from Candida albicans. Proteins (2008) 0.87
Pagetoid reticulosis (Woringer-Kolopp disease). J Dtsch Dermatol Ges (2008) 0.87
Serum- and glucocorticoid-inducible kinase SGK1 regulates reorganization of actin cytoskeleton in mast cells upon degranulation. Am J Physiol Cell Physiol (2012) 0.87
Isotopic response of graft versus host disease following herpes zoster infection: case report and review of the literature. Acta Derm Venereol (2012) 0.86
Cosmetic permanent fillers for soft tissue augmentation: a new contraindication for interferon therapies. Arch Dermatol (2007) 0.86
Age sensitivity of NFκB abundance and programmed cell death in erythrocytes induced by NFκB inhibitors. Cell Physiol Biochem (2013) 0.86
Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling. Am J Physiol Cell Physiol (2010) 0.86
Lactobacilli - bacteria-host interactions with special regard to the urogenital tract. Int J Med Microbiol (2005) 0.86
Phenotypic screening, transcriptional profiling, and comparative genomic analysis of an invasive and non-invasive strain of Candida albicans. BMC Microbiol (2008) 0.85
In vivo porphyrin production by P. acnes in untreated acne patients and its modulation by acne treatment. Acta Derm Venereol (2006) 0.85
Candida albicans PLD I activity is required for full virulence. Med Mycol (2004) 0.85
Treatment of disseminated granuloma annulare with low-dose fumaric acid. Acta Derm Venereol (2009) 0.85
Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo. PLoS Pathog (2010) 0.85
Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions. J Mol Med (Berl) (2010) 0.84
The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A. Proteins (2007) 0.83
Receptor-selective retinoids for psoriasis: focus on tazarotene. Am J Clin Dermatol (2006) 0.83
Tinea incognito hidden under apparently treatment-resistant pemphigus foliaceus. Acta Derm Venereol (2008) 0.83
PI3 kinase-dependent stimulation of platelet migration by stromal cell-derived factor 1 (SDF-1). J Mol Med (Berl) (2010) 0.83
[S2k-guideline for therapy of acne]. J Dtsch Dermatol Ges (2010) 0.83
Glycosylation of Candida albicans cell wall proteins is critical for induction of innate immune responses and apoptosis of epithelial cells. PLoS One (2012) 0.83
Treatment of ocular rosacea with once-daily low-dose doxycycline. Cornea (2014) 0.82
Y. enterocolitica inhibits antigen degradation in dendritic cells. Microbes Infect (2008) 0.82
Treatment of severe acne with low-dose isotretinoin. Acta Derm Venereol (2012) 0.82